RE: RNS18 Feb 2021 10:29
Broomfielder, likewise.
Have been a holder here for very many years. I have approx 20 shares with the sole target of making money. But two companies are different - AGL and SAR. I bought and hold these long term in my ISA to be a part, however small, of the battle against the ‘big C’. The latter has done very well recently, AGL also. It is good to see these rises, but for me it is not that important. What does really matter is that an increasing share price indicates progression towards commercialisation, and patients benefitting.
Yellow Budgie